Evidence map›Paper›PMID 37873755›Full record

ArticleThe Journal of international medical research2023

Impact of the COVID-19 pandemic on bladder cancer patients: a multicenter real-world study.

Yong Wei, Xiao Yang, Hongru Zhu, Juntao Zhuang, Lingkai Cai, Qianying Ji, Peng Chen, Qiang Cao, Wenhui Qian, Qingyi Zhu and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in The Journal of international medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yong WeiDepartment of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiao YangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hongru ZhuDepartment of Urology, Nanjing Gaochun People's Hospital, Nanjing, China.
Juntao ZhuangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Lingkai CaiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qianying JiDepartment of Urology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Peng ChenDepartment of Urology, Nanjing Gaochun People's Hospital, Nanjing, China.
Qiang CaoDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wenhui QianDepartment of Urology, Nanjing Gaochun People's Hospital, Nanjing, China.
Qingyi ZhuDepartment of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qiang LuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.ORCID 0000-0003-3589-2507
Jiangsu Province Hospital · CNGaochun People's Hospital · CNSecond Affiliated Hospital of Nanjing Medical University · CNNanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHospital management and medical treatment changed during the coronavirus disease 2019 (COVID-19) pandemic. This study investigated the impact of the COVID-19 pandemic on patients with bladder cancer.

methodsIn this multicenter retrospective study, we collected information from the electronic medical records of outpatients who underwent cystoscopy and inpatients with confirmed bladder cancer in three hospitals in Nanjing (two province-level and one county-level hospitals) in 2019 and 2020. Patients' home addresses, treatment methods, length of stay, and pathology were compared between the periods.

resultsIn total, 4048 outpatients and 1242 inpatients were included. The average number of cystoscopies decreased significantly during the lockdown. In province-level hospitals, the number of cystoscopies increased gradually as the pandemic was brought under control but remained lower than that in 2019, whereas the number grew in 2020 in county-level hospitals. The rates of recurrence and radical cystectomy were higher in 2020 than in 2019. No significant difference in the pathological grade was observed. More patients who underwent radical cystectomy were diagnosed with muscle-invasive bladder cancer during the 2020 lockdown.

conclusionThe pandemic severely affected patients with bladder cancer, mainly in their choice of institution and treatment.

Indexed as

COVID-19Urinary Bladder NeoplasmsCommunicable Disease ControlCystectomyHumansPandemicsRetrospective StudiesBladder cancerCOVID-19cystoscopymanagementradical cystectomyreal-worldrecurrence

Identifiers

PMID37873755
PMCPMC10594970
OpenAlexW4387893719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.